Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS

Katsuyuki Nakano; Terutoshi Nakao; Karl H. Schram; William M. Hammargren; Thomas D. McClure; Michael Katz; Esklid Petersen

doi:10.1016/0009-8981(93)90181-3

Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS

Katsuyuki Nakano, Terutoshi Nakao, Karl H. Schram, William M. Hammargren, Thomas D. McClure, Michael Katz, Esklid Petersen

Pharmacy Practice and Science

Research output: Contribution to journal › Article

65 Scopus citations

Abstract

Using boronate gel affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC), a method for the simultaneous determination of 12 urinary modified nucleosides has been developed. The RP-HPLC fractions were identified by gas chromatography/mass spectrometry analysis. The HPLC quantitation of urinary nucleoside levels before and after surgery of cancer patients suggested that urinary 5′-deoxy-5′-.

Original language	English (US)
Pages (from-to)	169-183
Number of pages	15
Journal	Clinica Chimica Acta
Volume	218
Issue number	2
DOIs	https://doi.org/10.1016/0009-8981(93)90181-3
State	Published - Sep 30 1993

ASJC Scopus subject areas

Biochemistry
Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1016/0009-8981(93)90181-3

Fingerprint Dive into the research topics of 'Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS'. Together they form a unique fingerprint.

Cite this

Nakano, K., Nakao, T., Schram, K. H., Hammargren, W. M., McClure, T. D., Katz, M., & Petersen, E. (1993). Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Clinica Chimica Acta, 218(2), 169-183. https://doi.org/10.1016/0009-8981(93)90181-3

@article{8ef24f3fcdbc409987dab53f177f66ff,

title = "Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS",

abstract = "Using boronate gel affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC), a method for the simultaneous determination of 12 urinary modified nucleosides has been developed. The RP-HPLC fractions were identified by gas chromatography/mass spectrometry analysis. The HPLC quantitation of urinary nucleoside levels before and after surgery of cancer patients suggested that urinary 5′-deoxy-5′-.",

author = "Katsuyuki Nakano and Terutoshi Nakao and Schram, {Karl H.} and Hammargren, {William M.} and McClure, {Thomas D.} and Michael Katz and Esklid Petersen",

year = "1993",

month = sep,

day = "30",

doi = "10.1016/0009-8981(93)90181-3",

language = "English (US)",

volume = "218",

pages = "169--183",

journal = "Clinica Chimica Acta",

issn = "0009-8981",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS

AU - Nakano, Katsuyuki

AU - Nakao, Terutoshi

AU - Schram, Karl H.

AU - Hammargren, William M.

AU - McClure, Thomas D.

AU - Katz, Michael

AU - Petersen, Esklid

PY - 1993/9/30

Y1 - 1993/9/30

N2 - Using boronate gel affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC), a method for the simultaneous determination of 12 urinary modified nucleosides has been developed. The RP-HPLC fractions were identified by gas chromatography/mass spectrometry analysis. The HPLC quantitation of urinary nucleoside levels before and after surgery of cancer patients suggested that urinary 5′-deoxy-5′-.

AB - Using boronate gel affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC), a method for the simultaneous determination of 12 urinary modified nucleosides has been developed. The RP-HPLC fractions were identified by gas chromatography/mass spectrometry analysis. The HPLC quantitation of urinary nucleoside levels before and after surgery of cancer patients suggested that urinary 5′-deoxy-5′-.

UR - http://www.scopus.com/inward/record.url?scp=0027329792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027329792&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(93)90181-3

DO - 10.1016/0009-8981(93)90181-3

M3 - Article

C2 - 7508341

AN - SCOPUS:0027329792

VL - 218

SP - 169

EP - 183

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 2

ER -